Vironix - Vironix
Shield your organisation from a viral outbreak
Find out more
Rapid Assesment & Early Detection
Find out more
The Communication of Dedicated Distribution
Find out more
The Communication of Dedicated Distribution
Find out more
The Communication of Dedicated Distribution
Find out more
Now more than ever, global organizations are feeling the economic, social, and public health impact of viral and chronic respiratory illness.
Created in collaboration with scientists, disease specialists, mathematicians and patient care experts, Vironix is the only institutional wellness software that merges disease-specific clinical science with machine-learned prediction methods to enable early, targeted, and effective intervention on the most prevalent and costly infectious and chronic illnesses.

Rapid assessment

CovidX is helping employers and employees to self-monitor their symptoms and signs, catch infections early, and improve their overall health while putting privacy and data security front and center!
Find out more

Early Detection

Early detection of health deterioration is key to facilitating rapid symptom management and minimizing infection spread within organizations of all sizes
Find out more

User Privacy

Developed under FDA guidelines, CovidX is a patient decision support software that minimizes unnecessary health data transmission between institutions and individuals.
Find out more

Safety Guidelines

CovidX can provide employers with personalized summary health scores to facilitate work-from home strategies on local and global scales
Find out more

Institutional Wellness

Global employers, health insurers, governments and hospitals are hungry for solutions that enable early identification and intervention on preventable illness. Vironix has built a crucial software platform that raises organizational wellness, reduces traumatic and costly instances of member sickness, and mitigates company infection spread while putting individual privacy front and center.

The Science behind Vironix

Read about the development and validation of our disease-specific prediction algorithms

Vironix News

What they say about Vironix